February 9, 2012 -- YARDLEY, Pa. -- The first patients have been successfully enrolled in a phase III study involving the intranasal delivery of... […]
February 2, 2012 -- YARDLEY, Pa. -- OptiNose Inc. announces the filing of an Investigational New Drug (IND) with the U.S. Food and Drug Administration […]
December 1, 2011 -- NEW YORK, Dec. 23, 2011 /PRNewswire/ --AaTheraBiogen, Inc. (OTC BB: TRAB), a manufacturer and distributor of homeopathic nasal spr […]